Yourgene Health Cystic Fibrosis Base assay receives IVDR accreditation
Yourgene Health (part of the Novacyt group of companies), a leading international molecular diagnostics group, announces that it has received accreditation under the new EU requirements of the in vitro diagnostic regulation (IVDR) for the Yourgene® Cystic Fibrosis Base
Cellular Origins, Fresenius Kabi sign development agreement for scalable automation of cell and gene therapy manufacturing
Companies to develop integration strategies for Fresenius Kabi’s portfolio of Cell Therapy Technologies within Cellular Origins’ Constellation automation platform Initial research to focus on integration of the Cue® Cell Processing System for automated sma
Nuclera closes $75 million USD financing
Series C round led by Elevage Medical Technologies. Funding will accelerate the commercialization of Nuclera’s eProtein Discovery platform, to optimize protein expression and purification workflows within research labs globally.
Sapio Sciences Enhances Bioanalysis LIMS and ELN with Advanced Immunogenicity Capabilities
Enhancements support ADA and NAb testing workflows, boosting lab efficiency and regulatory compliance for drug developmentBaltimore, MD – Sapio Sciences, the science-aware™
Shift Bioscience raises $16M to advance cell simulation AI platform
Investment led by BGF, with support from existing investors F-Prime Capital, Kindred Capital, and Jonathan Milner Seed funding will accelerate development of Shift Bioscience’s platform for identification of safe rejuvenation genes, a fundamental step forward in the
Menopause matters – how to support staff going through menopause
Menopause will affect almost half the workforce in the UK. But this natural stage of life is still taboo for lots of employers. This Menopause Awareness Month, we’re looking at how to create a supportive environment for menopausal employees.
Guardtech Group bag third win in two months with West Suffolk Innovation of the Year Award
Haverhill-based cleanroom construction specialists scoop Bury Free Press Awards win for Innovation with portable container business Cleancube Mobile Cleanrooms
Antiverse raises £3.5M ($4.6M) to advance generative AI antibody design platform
Increases total equity financing raised to £7.2M ($10.1M) New facilities in Boston and Prague will provide increased capacity to deliver pipeline of pharma and biotech projects Funding to progress internal assets targeting multiple GPCRs and Ion
Leadership change at CMR Surgical
CMR Surgical, the global surgical robotics business, announces the appointment of Massimiliano Colella as Interim Chief Executive Officer as Supratim Bose transitions to Vice-Chairman of the Board.
Benefits of a Nitrosamine Selective Detector
Nitrosamines, such as N-Nitrosodimethylamine (NDMA), are carcinogenic compounds that can form during the drug manufacturing process and storage under certain conditions.
Ensuring cosmetic safety: the vital role of ATNC analysis
Cosmetics aren't just about enhancing beauty; they're about trust and safety. In the intricate dance of beauty and science, the discovery of nitrosamines within our cherished products has cast a shadow, highlighting the need for safety measures.
Alleo and Ubiquigent enter AI-driven strategic partnership to accelerate DUB-focused drug discovery
Collaboration will combine Alleo’s AI-based platform with Ubiquigent’s expertise in the DUB space to advance DUB-focused preclinical programmes
Digital marketing for B2B in China: what you need to know and how to do it
China is rapidly evolving into the world’s most digitised economy, making digital marketing essential for any company aiming to succeed there.
Helping rediscover purpose and fulfilment after retirement: Barry’s story
After a long career in engineering, Barry decided to retire when the company closed his office. But adjusting to life outside of work was a struggle – he found it difficult to fill his days and he lost the sense of purpose his job had given him. With the right guidance and support, Barry discovered a new passion that’s now helping him to grow his skills and find fulfilment in the next stage of…
Research sets global standard for Crohn’s treatment
Trial results published by Cambridge researchers earlier this year and involving patients at Addenbrooke’s Hospital are helping to set new global standards for the treatment of Crohn’s disease, it has emerged.
Qkine wins ‘Scale-up of the Year’ at the 2024 Cambridge Independent Business Awards
On the 26th September 2024, Qkine representatives Catherine Elton, CEO and Luana Ferrara, Head of R&D and Collaborations joined some of the most impressive Cambridge business leaders for an exciting evening of networking and entertainment at the Cambridge Independent Business awards ceremony held in the spectacular Great Hall at King’s College, Cambridge.
AstraZeneca unveils The Hub, a new amenities centre, on Cambridge Biomedical Campus
AstraZeneca has today officially opened The Hub in Cambridge, a purposely designed amenities centre, where employees and the local community can collaborate, socialise and unwind. Located at the heart of the Cambridge Biomedical Campus (CBC), The Hub offers a wide range of facilities and services, including a day nursery, pre-school, shop, café area and garden that are open to the wider CBC…
DREAM: Develop, Research, Engineer, Assemble and Manufacture with a Guardtech Cleanrooms modular
The Guardtech Group’s more modest modular specialists are helping applications reach new levels with their affordable yet high-quality systems
Innovative bioscience and lifesaving research shine during Mayor's campus visit
Dr Nik Johnson, Mayor of Cambridgeshire and Peterborough, visited Cambridge Biomedical Campus to find out more about its contribution to the local economy and its role as the base for world-class healthcare, pioneering bioscience and innovation-led business growth.
Virtual reality helps to alleviate pain and anxiety in palliative patients at Addenbrooke's
Supporters of Addenbrooke's Charitable Trust have helped alleviate pain and anxiety in palliative patients being cared for at Addenbrooke's by funding the lease of a virtual reality headset. Now a past patient who used the virtual reality headset has left a donation in her will to fund the purchase of a headset which means many more palliative patients will be able to benefit from using virtual…
Innovative mental health research partnership launches to study new therapies
People across Cambridgeshire and Peterborough with severe mental health conditions now have the opportunity to take part in local groundbreaking clinical trials, to assess if empathogens and psychedelics can help people with treatment-resistant conditions.
Survivor David backs ‘Restart a Heart’ campaign
A devoted Cambridge United fan who received life-saving treatment at a packed home match has today applauded a month-long initiative aimed at teaching the public CPR – officially called cardiopulmonary resuscitation.
Rehabilitation therapists present their research at international spinal cord conference
CPFT NEWS ARTICLE Two allied health professionals, who joined CPFT’s Cambridge Rehabilitation Unit this year, shared their research on spinal cord injury at the International Spinal Cord Society Annual Meeting last month. Senior Physiotherapist Ishmeet Singh (pictured left) was selected to present his findings from a randomised controlled trial testing how computer-based exergaming can improve…
CUH begins ground-breaking genetic screening for newborn babies
Dozens of babies at the Rosie hospital have begun to be tested for over 200 rare genetic conditions as part of a world-leading study.
Cambridge Network collaborates with ARIA and key partners to accelerate new technologies to revolutionise brain health
Cambridge Network is thrilled to announce its participation in a multi-million-pound, three-year multi-partner programme with the UK Government’s new research funding agency Advanced Research and Invention Agency (ARIA). As one of ARIA’s new Activation Partners in the agency’s Scalable Neural Interfaces opportunity space, this collaboration aims to rocket-boost progress on a new generation of…